Qt Imaging Holdings (QTI) Net Income towards Common Stockholders (2021 - 2026)
Qt Imaging Holdings' (QTI) quarterly Net Income towards Common Stockholders came in at -$11.1 million in Q2 2026, down 176.61% year-over-year from $14.4 million in Q2 2025, and down 225.01% quarter-over-quarter from -$3.4 million in Q1 2026.
Analysis
Qt Imaging Holdings (QTI) Net Income towards Common Stockholders (2021 - 2026) Analysis & Trends
Qt Imaging Holdings (QTI) has reported Net Income towards Common Stockholders for 6 consecutive years, with -$11.1 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Net Income towards Common Stockholders fell 176.61% year-over-year to -$11.1 million in Q2 2026; TTM through Jun 2026 was -$20.4 million, a 8.2% increase from a year earlier, with the FY2025 full-year figure at -$21.1 million, down 48.78% from the prior year.
- Net Income towards Common Stockholders was -$11.1 million for Q2 2026 at Qt Imaging Holdings, down from -$3.4 million in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at -$382333.0 in Q1 2022 and troughed at -$11.1 million in Q1 2025.
- A 5-year average of -$3.5 million and a median of -$2.6 million in 2023 frame the typical range for Net Income towards Common Stockholders.
- Across the five-year window, Net Income towards Common Stockholders plunged 969.49% in 2022 and jumped 69.41% in 2026, its largest moves.
- Over 5 years, Net Income towards Common Stockholders stood at -$1.6 million in 2022, then rose by 6.44% to -$1.5 million in 2023, then plunged by 131.02% to -$3.5 million in 2024, then surged by 60.21% to -$1.4 million in 2025, then slumped by 697.51% to -$11.1 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at -$11.1 million (Q2 2026), -$3.4 million (Q1 2026), and -$1.4 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 1.48 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 1.28 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 907.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 241.40 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 249.10 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Qt Imaging Holdings | 39.82 Mn | 28.90 Mn | 3.06 Mn | -11.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -11.07 Mn |
| Mar 31, 2026 | -3.41 Mn |
| Dec 31, 2025 | -1.39 Mn |
| Sep 30, 2025 | -4.56 Mn |
| Jun 30, 2025 | -4.00 Mn |
| Mar 31, 2025 | -11.14 Mn |
| Dec 31, 2024 | -3.49 Mn |
| Sep 30, 2024 | -3.62 Mn |
| Jun 30, 2024 | -6.43 Mn |
| Mar 31, 2024 | -4.30 Mn |
| Dec 31, 2023 | -1.51 Mn |
| Sep 30, 2023 | -1.38 Mn |
| Jun 30, 2023 | -1.33 Mn |
| Mar 31, 2023 | -1.81 Mn |
| Dec 31, 2022 | -1.61 Mn |
| Sep 30, 2022 | -1.08 Mn |
| Jun 30, 2022 | -846,652.00 |
| Mar 31, 2022 | -382,333.00 |
| Dec 31, 2021 | -871,859.00 |
| Sep 30, 2021 | -204,317.00 |